NCT05215054View on ClinicalTrials.gov

Clinical Study for the Evaluation of the Safety and Effectiveness of Use of a Poly-L Lactic Acid Injectable Filler for the Aesthetic Treatment of Nasolabial Folds

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

March 7, 2022

Primary Completion Date

November 7, 2022

Study Completion Date

May 7, 2024

Conditions
Wrinkle
Interventions
DEVICE

Gana V®

Injection in the deep dermis and subcutaneous layer of the nasolabial fold on D0 (initial injection) and 1 month and a half after initial injection if necessary (optional touch-up).

DEVICE

Sculptra®

Injection in the deep dermis and subcutaneous layer of the nasolabial fold on D0 (initial injection) and 1 month and a half after initial injection if necessary (optional touch-up).

Trial Locations (1)

69100

Eurofins Dermscan Pharmascan, Villeurbanne

All Listed Sponsors
collaborator

Eurofins Dermscan Pharmascan

INDUSTRY

lead

GCS Co., Ltd

INDUSTRY